Literature DB >> 9811900

U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in culture.

A Rotola1, T Ravaioli, A Gonelli, S Dewhurst, E Cassai, D Di Luca.   

Abstract

Human herpesvirus 6 (HHV-6) like other herpesviruses, expresses sequentially immediate early (IE), early, and late genes during lytic infection. Evidence of ability to establish latent infection has not been available, but by analogy with other herpesviruses it could be expected that IE genes that regulate and transactivate late genes would not be expressed. We report that peripheral blood mononuclear cells of healthy individuals infected with HHV-6 express the U94 gene, transcribed under IE conditions. Transcription of other IE genes (U16/17, U39, U42, U81, U89/90, U91) was not detected. To verify that U94 may play a role in the maintenance of the latent state, we derived lymphoid cell lines that stably expressed U94. HHV-6 was able to infect these cells, but viral replication was restricted. No cytopathic effect developed. Furthermore, viral transcripts were present in the first days postinfection and declined thereafter. A similar decline in the level of intracellular viral DNA also was observed. These findings are consistent with the hypothesis that the U94 gene product of HHV-6 regulates viral gene expression and enables the establishment and/or maintenance of latent infection in lymphoid cells.

Entities:  

Mesh:

Year:  1998        PMID: 9811900      PMCID: PMC24961          DOI: 10.1073/pnas.95.23.13911

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Latent human herpesvirus 6 infection of human monocytes/macrophages.

Authors:  K Kondo; T Kondo; T Okuno; M Takahashi; K Yamanishi
Journal:  J Gen Virol       Date:  1991-06       Impact factor: 3.891

2.  High prevalence of antibody to human herpesvirus-6 and decrease in titer with increase in age in Japan.

Authors:  K Yanagi; S Harada; F Ban; A Oya; N Okabe; K Tobinai
Journal:  J Infect Dis       Date:  1990-01       Impact factor: 5.226

3.  Identification of proteins specific for human herpesvirus 6-infected human T cells.

Authors:  N Balachandran; R E Amelse; W W Zhou; C K Chang
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

4.  Herpes simplex virus type 1 latency-associated transcripts suppress viral replication and reduce immediate-early gene mRNA levels in a neuronal cell line.

Authors:  N Mador; D Goldenberg; O Cohen; A Panet; I Steiner
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

5.  Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation.

Authors:  D R Carrigan; W R Drobyski; S K Russler; M A Tapper; K K Knox; R C Ash
Journal:  Lancet       Date:  1991-07-20       Impact factor: 79.321

6.  Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells.

Authors:  J L Yates; N Warren; B Sugden
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

7.  Human herpesvirus 6 infection in renal transplantation.

Authors:  T Okuno; K Higashi; K Shiraki; K Yamanishi; M Takahashi; Y Kokado; M Ishibashi; S Takahara; T Sonoda; K Tanaka
Journal:  Transplantation       Date:  1990-03       Impact factor: 4.939

8.  Acquisition of the human adeno-associated virus type-2 rep gene by human herpesvirus type-6.

Authors:  B J Thomson; S Efstathiou; R W Honess
Journal:  Nature       Date:  1991-05-02       Impact factor: 49.962

9.  Prominence of the herpes simplex virus latency-associated transcript in trigeminal ganglia from seropositive humans.

Authors:  J G Stevens; L Haarr; D D Porter; M L Cook; E K Wagner
Journal:  J Infect Dis       Date:  1988-07       Impact factor: 5.226

10.  Identification of human herpesvirus-6 as a causal agent for exanthem subitum.

Authors:  K Yamanishi; T Okuno; K Shiraki; M Takahashi; T Kondo; Y Asano; T Kurata
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

View more
  39 in total

1.  Identification of human herpesvirus 6 latency-associated transcripts.

Authors:  Kazuhiro Kondo; Kazuya Shimada; Junji Sashihara; Keiko Tanaka-Taya; Koichi Yamanishi
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Human herpesvirus 6 infects and replicates in aortic endothelium.

Authors:  A Rotola; D Di Luca; E Cassai; D Ricotta; A Giulio; A Turano; A Caruso; C Muneretto
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

3.  Long-lasting CD3+ T-cell deficiency after cord blood stem cell transplantation in a human herpesvirus 6-infected child.

Authors:  Manola Comar; Pierlanfranco D'Agaro; Douglas Horejsh; Monica Galvan; Simona Fiorentini; Marino Andolina; Arnaldo Caruso; Dario Di Luca; Cesare Campello
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 4.  Roseolovirus molecular biology: recent advances.

Authors:  Laurie T Krug; Philip E Pellett
Journal:  Curr Opin Virol       Date:  2014-11-27       Impact factor: 7.090

Review 5.  Herpesvirus latency.

Authors:  Jeffrey I Cohen
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

6.  Detection of antibodies directed against human herpesvirus 6 U94/REP in sera of patients affected by multiple sclerosis.

Authors:  Elisabetta Caselli; Michela Boni; Arianna Bracci; Antonella Rotola; Claudio Cermelli; Massimiliano Castellazzi; Dario Di Luca; Enzo Cassai
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

7.  Variant-specific tropism of human herpesvirus 6 in human astrocytes.

Authors:  Donatella Donati; Elena Martinelli; Riccardo Cassiani-Ingoni; Jenny Ahlqvist; Jean Hou; Eugene O Major; Steve Jacobson
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 8.  Laboratory and clinical aspects of human herpesvirus 6 infections.

Authors:  Henri Agut; Pascale Bonnafous; Agnès Gautheret-Dejean
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 9.  Human herpesvirus 6: An emerging pathogen.

Authors:  G Campadelli-Fiume; P Mirandola; L Menotti
Journal:  Emerg Infect Dis       Date:  1999 May-Jun       Impact factor: 6.883

10.  Human herpesvirus 6A infection in CD46 transgenic mice: viral persistence in the brain and increased production of proinflammatory chemokines via Toll-like receptor 9.

Authors:  Joséphine M Reynaud; Jean-François Jégou; Jérémy C Welsch; Branka Horvat
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.